AICAR and nicotinamide treatment synergistically augment the proliferation and attenuate senescence-associated changes in mesenchymal stromal cells
Abstract Background Mesenchymal stromal cell (MSC) stemness capacity diminishes over prolonged in vitro culture, which negatively affects their application in regenerative medicine. To slow down the senescence of MSCs, here, we have evaluated the in vitro effects of 5-aminoimidazole-4-carboxamide ri...
Main Authors: | Mohammadhossein Khorraminejad-Shirazi, Mahsa Sani, Tahereh Talaei-Khozani, Mohammadreza Dorvash, Malihe Mirzaei, Mohammad Ali Faghihi, Ahmad Monabati, Armin Attar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-020-1565-6 |
Similar Items
-
AICAR inhibits ceramide biosynthesis in skeletal muscle
by: Erickson Katherine A, et al.
Published: (2012-11-01) -
Modulation de la voie HIPPO par un métabolite aux propriétés anti-tumorales : l'AICAR
by: Philippe, Chloe
Published: (2016) -
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway
by: Chia-Cheng Su, et al.
Published: (2019-04-01) -
5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
by: Lisa Maria Martin, et al.
Published: (2019-07-01) -
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review
by: Dora Višnjić, et al.
Published: (2021-05-01)